Masahiko Tanabe

11PUBLICATIONS
32CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 26, 2024
Patient survey on cancer genomic medicine in Japan under the national health insurance system.

Hidenori Kage, Nana Akiyama, Hyangri Chang

|Nov 25, 2023
Predicting Breast Cancer Risk Using Radiomics Features of Mammography Images.

Yusuke Suzuki, Shouhei Hanaoka, Masahiko Tanabe

|May 11, 2023
Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan.

Hidenori Kage, Katsutoshi Oda, Manabu Muto

|Apr 20, 2023
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.

Takuji Iwase, Shigehira Saji, Kotaro Iijima

|Jan 05, 2023
Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan.

Hidenori Kage, Aya Shinozaki-Ushiku, Kazunaga Ishigaki

|Sep 09, 2022
Subcutaneous axillary primary epithelioid hemangioendothelioma: report of a rare case.

Takayoshi Niwa, Takaaki Konishi, Asako Sasahara

Pageof 2